The AGITG ICECREAM STUDY: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation- analysis of outcomes in patients with refractory metastatic colorectal cancer harbouring the KRAS G13D mutation.

Eva Segelov, Subotheni Thavaneswaran, Paul Waring, Jayesh Desai, Kirsty Mann, Maria Elena Elez, Lorraine A Chantrill, Nick Pavlakis, Louise Nott, C Underhill, Mustafa Khasraw, Harpreet Wasan, Fortunato Ciardiello, Michael J Jefford, Warren Joubert, Andrew Mark Meurisse Haydon, Christos Karapetis, Tim J. Price, Kate Wilson, Jeremy Shapiro

Research output: Contribution to conferenceAbstract

Original languageEnglish
Number of pages1
Publication statusPublished - 2015
Externally publishedYes

Cite this